Table of Contents
CHAPTER 01: COMPANY OVERVIEW 3
1.1 Introduction 3
1.2 Basic Information and Chronology since Inception 4
1.3 Vision 5
1.4 Mission 5
1.5 Objective 5
1.6 Corporate Focus 5
1.7 Management Philosophy 5
CHAPTER 02: INDUSTRY ANALYSIS 7
2.1 Rivalry among existing firms 7
2.2 Threat of entry of new firms 9
2.3 Threat of Substitute products or Services 10
2.4 Bargaining power of suppliers 10
2.5 Bargaining power of buyers 11
CHAPTER 03: COMPANY ANALYSIS 13
3.1 SWOT ANALYSIS 13
3.1.1 STRENGTHS: 13
3.1.2 WEAKNESSES: 14
3.1.3 OPPORTUNITIES: 14
3.1.4 THREATS: 15
3.2 Competitive Strategy Analysis: 16
3.2.1 Advantage of SPL in using an Integrated Strategy: 17
3.2.2 ...view middle of the document...
The company also provides local anesthetics, other antibacterials, beta-lactam antibiotics, penicillins and cephalosporins, NSAIDs and antigout preparations, quinolone antibiotics, respiratory tract preparations, systemic antifungal, antiviral and antiprotozoal agents, systemic hormone, systemic sex hormone, thyroid therapy, topical preparations, vitamins and minerals, and water purification products. In addition, its animal health products consist of livestock, poultry, and aqua products. Further, the company offers agro chemical products comprising insecticides, nematicides, fungicides, herbicides and public health insecticides, as well as active pharmaceutical ingredients.
SQUARE today symbolizes a name - a state of mind. But its journey to the growth and prosperity has been no bed of roses. From the inception in 1958, it has today burgeoned into one of the top line conglomerates in Bangladesh. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on its way to becoming a high performance global player.
1.2 Basic Information and Chronology since Inception
Year of establishment(Initially as a partnership) | 1958 |
Incorporated as a private Limited Company | 1964 |
Technical collaboration agreement with Janssen Pharmaceuticals of Belgium (a subsidiary of Jhonson & Jhonson International Ltd.) | 1975 |
Technical collaboration agreement with F. Haffman-La Rache & co. Ltd. | 1984 |
Converted into Public Limited company | 1991 |
Initially Public Offering (IPO) | 1994 |
Stock Exchange listing | 1995 |
Agreement with M/s Bovis Tanvec Ltd. Of UK for Implementation of Dhaka Plant | 1996 |
Awarded ISO-9001 Certificates | 1998 |
Awarded UK-MHRA Certificates | 2007 |
Started manufacturing of insulin maintaining quality standards of US FDA & MHRA. | 2009 |
Business lines | Manufacturing & Marketing of Pharmaceutical finished Products, Basic Chemicals, Agro vet products & pesticide products. |
Authorized Capital | TK. 5,000 million |
Paid-up Capital | TK. 3708.0 million |
Current Share Price (14.04.2013) | Tk. 178.00 |
Subsidiary Company | Square Spinning Ltd.Square Cephalosporin’s Ltd.Square Biotech’s Ltd. |
Associate Company | Square Textile Ltd.Square Knit Fabrics Ltd.Square Fashions Ltd.Square Hospitals Ltd. |
Square views business as a means to the material and social wellbeing of the investors, employees and the society at large, leading to accretion of wealth through financial and moral gains as a part of the process of the human civilization.
So, we can say that its Vision is focused on different stakeholders, i.e., People oriented.
Its Mission is to produce and provide quality & innovative healthcare relief for people, maintain stringently ethical standard in business operation also ensuring benefit to the shareholders, stakeholders and the society at large.
So, we can say...